Redox control at the ER-mitochondria interface in kidney transplantation: MAM-centered stress signaling and

Baicheng Kuang1, Lin Han2, Sopheaktra Tan3

  • 1Institute of Organ Transplantation, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Key Laboratory of Organ Transplantation, Ministry of Education, Chinese Academy of Medical Sciences, NHC Key Laboratory of Organ Transplantation, Wuhan, 430030, China; Tongji Junshan Neuroscience Center, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430030, China.

Redox Biology
|May 28, 2026
PubMed

Insights

Kidney transplant ischemia-reperfusion injury involves oxidative and endoplasmic reticulum (ER) stress. Targeting mitochondria-associated membranes (MAMs) offers a novel strategy to improve kidney graft survival.

Area of Science:

  • Nephrology
  • Cellular Biology
  • Transplantation Immunology

Background:

  • Ischemia-reperfusion injury (IRI) is a major cause of kidney transplant failure.
  • Oxidative stress and endoplasmic reticulum (ER) stress are key contributors to IRI, driving mitochondrial dysfunction and inflammation.
  • The interplay between these stresses and their convergence at mitochondria-associated membranes (MAMs) is not fully understood.

Purpose of the Study:

  • To propose a MAM-centered framework integrating cellular stress responses in kidney IRI.
  • To highlight therapeutic strategies targeting MAM-associated pathways.
  • To discuss kidney organoid platforms for studying MAM dynamics.

Main Methods:

  • Review of existing literature on oxidative stress, ER stress, and MAMs in kidney IRI.
  • Analysis of therapeutic strategies targeting MAMs.
  • Discussion of kidney organoid models for translational research.

Main Results:

  • MAMs integrate oxidative and ER stress, influencing mitochondrial function and cell fate.
  • Targeting MAM-associated pathways, including antioxidants and ER proteins, shows therapeutic potential.
  • Kidney organoids provide a human-relevant model for investigating MAM dynamics.

Conclusions:

  • A MAM-centered approach is crucial for understanding and mitigating kidney IRI.
  • Targeting MAMs offers promising therapeutic avenues for improving kidney transplant outcomes.
  • Organoid platforms facilitate the translation of mechanistic insights into clinical applications.